U p TO 60% OF MULTI -TRANSFUSED ADULT FACTOR VIIIdeficient hemophiliacs in the Canadian population were infected with the human immunodeficiency virus (HIV) starting in the early part of the past decade as a consequence of infected pooled factor concentrates (1,2). The majority of these individuals has now had concomitant HIV infection and hemophilia for at least 10 years and can be expected to exhibit many manifestations of their progressively impaired immunity. Septic arthritis has been considered to be a rare event in hemophilia, with an estimated incidence of 0.15% per year (3-5 , 10) . This is only three to 12 times the incidence of septic arthritis in the general population (8) . The first reported case of septic arthritis in an HIVinfected hemophiliac was in 1989 (6) .
We report two cases of multiple pyarthroses in HIVinfected hemophiliacs presenting with what appeared to be single joint hemorrhages. These cases are presented to illustrate the serious consequences of altered immunity and HIV-associated neutropenia in hemophiliacs with concomitant hemarthropathy and the need to question the traditional therapeutic principle of 'if in doubt, infuse' in the HIV-infected hemophiliac.
CASE ONE
A 34-year-old male with severe hemophilia A (factor V1II activity less than 0.01 U/mL) and multiple chronic hemarthropathies presented with 48 h of intermittent spiking fever and pain and swelling in both knees. The patient had been self-infusing 2500 U of factor V1II concentrate every 12 h over the previous two days on the assumption that the symptoms represented hemorrhages.
This patient had advanced immune disease with a CD4 count before admission of less than l00xl0 9 /L. He had no acquired immunodeficiency syndrome (AIDS)-defining illnesses, except recent wasting. At admission, the patient's temperature was 38.8°C, heart rate was 108 beats/min, and blood pressure was 160/80 mmHg. He had severe hemophiliac arthropathy in both elbows, ankles, and knees. Swelling, erythema, warmth and exquisite pain were present in both knees and in the right elbow. Initial white blood cell count was l.8xl0 9 /L with an absolute neutrophil count of l.l34xl0 9 /L.
Blood cultures were done at admission and the patient was placed on intravenous piperacillin and gentamicin, and appropriate factor V1II replacement was infused. He continued to be febrile with unremitting joint pain and, at 48 h post admission, the left knee was aspirated, yielding 20 mL of frank pus. A heavy growth of Staphylococcus aureus was present from knee and blood samples. Cloxacillin was substituted for piperacillin. As the patient continued to be febrile with a low neutrophil count, on the fifth day, granulocyte colonystimulating factor (G-CSF) (Neupogen Filgrastin, Amgen Inc) therapy was instituted using 300 1-<g/day, with a was discharged on the 16th hospital day on cloxacillin and rifampin by mouth. He had a lengthy convalescence, and after three months still had decreased range of motion in the affected joints.
CASE TWO
A 27 -year-old male with severe hemophilia A (factor V1II activity less than 0.01 U/mL) presented with thre:e days of fever, shaking chills and right elbow and bilateral knee swelling. He had been seen as an outpatient 72 h before admission with a painful, swollen right elbow (Figure 1) . A clinical diagnosis of hemarthro~is had been made and he was instructed to infuse factor V1II 2500 U every 12 h for the next 72 h, and to retum if resolution did not occur.
The patient had a dvanced immune disease with a CD4 count ofless than lOOxl0 9 /L before admission. He had no AJDS-defming illnesses except for recent wasting. The patient had total arthroplasty of the right knee ori.e year before admission. The patient also had chronic elevation of liver enzymes, hepatomegaly, positive hepatitis C virus (HCV) antibody, clinically consistent with HCV-induced chronic active hepatitis. On admission, temperature was 38.3°C, heart rate was 160 beats/min, and blood pressure 110/40 mmHg. The patient was drowsy. Both elbows (Figure 1) . knees, and ankles were erythematous, swollen, warm and exquisitely painful. Prompt aspiration of the right knee yielded 100 mL of sanguineous fluid, which revealed Gram-positive cocci on Gram's staining. Subsequent cultures from the aspirate and from blood grew S aureus. Admission white blood cell count was 3.6x10 9 /L with an absolute neutrophil count of 2.18xl0
The patient was placed on cloxacillin and gentamicin intravenously, but continued to be febrile and variably encephalopathic. He developed palpable purpura on both legs, which was considered lo be secondary to systemic infection (Figure 2 ). On the sixlh hospital day. the absolute neutrophil counl wa l.8x10
9 /L. The patient was started on G-CSF therapy at 300 11g/day. with a prompt rise in the absolute neutrophil counl to 9.0x10 9 /L. The patient's fever resolved but the right elbow showed continuing evidence of pyarthrosis (Figure 3) . He became increa ingly jaundiced over the next seven days, with a rise in serum bilirubin to 450 mmol/L. On the 18th hospital day. renal failure developed and lhe patient died on the 22nd hospital day as a consequence of his hepatorenal syndrome. An autopsy was nol obtained .
DISCUSSION
A hemophiliac with intra-articular bleeding displays a warm. swollen. painful joint similar lo the clinical findings in septic arthritis. To date, there has been reluctance to aspirate these joinl because of the frequency of their occurrence, and in lhe severely affected hemophiliac. the possibility of inducing further bleeding (7). Generally, conservative management with rest. ice and immediate appropriate factor infusion sufficed. although severe hemarthropathy was the all lao common result of the numerous bleeding episodes in these patients. Prompt factor replacement was also necessary, as the hemophiliac often experienced the ·aura· of a hemorrhage before clinical signs become evident.
The actual rate of S aureus infections in IIIV-infected hemophiliacs is not well studied. desp ite reports describing septic arthritis in hemophiliac patients since 1983 (3 -5, 12, 13). However. il has recently been observed that joint infections are more prevalent in hemophiliacs than has been previously desc1ibed (8.9, 12) .
Several authors have suggested that these infections result from a preceding bacteremia in an immunocompromised individual (10.11). S aureus bacteremia occurs at an estimated rate of 0.16% per annum in nonintravenous drug abusing HIV-infected patients with AIDS or AIDS-re lated complex (14) . Late metastatic complications occur in approximately one-third of cases. Increased colonization rate, cutaneous abnormalities and granulocyte dysfunction all likely play a role in the increased incidence of S aureus bacteremia (13.14). Joint pathology in hemophiliacs likely provides a site for seeding during bacteremia. as was demonstrated in the patients described.
Bas d upon the experience with these two cases, one of which proved fatal, and the other requiring prolonged hospitalization and rehabilitation. the following are recommended considerations for the treatment of joint hemorrhage in HIV-infected hemophiliacs. Diagnosis : First, if a single joint hemorrhage does not respond to appropriate factor replacement in 24 h, joint aspiration should be performed in association with blood culture and empirical antimicrobial therapy , including staphylococcal coverage initiated pending cuilure results.
Second, any joint hemorrhage associated with a patient's temperature of greater than 38.5°C should be aspirated and examined in association with blood cultures. One series revealed a temperature greater than 38.5°C in nine of 11 patients with pyogenic arthritis, and in only one of 67 with a hemarthrosis (13) .
Third, if more than one joint has apparent simultaneous hemorrhage. then aspirations and blood cultures should be performed (6) . While the frequency of multiple joint involvement in hemophiliacs with septic joints has not been reported, it appears to be more common than the multiple simultaneous hemarthrosis rate of 3.7% quoted in one large series (15) . Treatment: If Gram's stain is positive, immediate appropriate intravenous antibiotic therapy must be initiated. This shou ld be continued for a six-week period.
If the individual has an absolute neutrophil count of less than 1.0x10 9 /L, empirical intravenous antibiotic therapy is indicated unW pyarthrosis has b een excluded.
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